Page last updated: 2024-10-18

dalteparin and Angioma

dalteparin has been researched along with Angioma in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Angioma: A vascular anomaly due to proliferation of blood or lymphatic vessels that forms a tumor-like mass. Vessels in the angioma may or may not be dilated.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Serrano, F1
Bisdorff-Bresson, A1
Sroussi, J1
Aymard, A1
Wassef, M1
Civelli, V1
Boujlel, S1
Houdart, E1
Drouet, L1

Other Studies

1 other study available for dalteparin and Angioma

ArticleYear
Giant intrahepatic venous malformation with localized intravascular coagulopathy. Follow-up and treatment during pregnancy.
    Journal de medecine vasculaire, 2020, Volume: 45, Issue:6

    Topics: Abortion, Habitual; Adult; Anticoagulants; Blood Coagulation Disorders; Cesarean Section; Enoxaparin

2020